News

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertisement — Advertise with Biotech Networks
No Picture
News

Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.

PALO ALTO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of […]

No Picture
News

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced positive preclinical data on weight loss effects for NPM-115, the Company’s miniature, […]

Advertisement — Advertise with Biotech Networks
Advertisement — Advertise with Biotech Networks
News

AbbVie pays OSE Immunotherapeutics $48M upfront for early-stage antibody targeting chronic inflammation

AbbVie is making good on its plans to search for new mechanisms of action, this time with French biotech OSE Immunotherapeutics for a monoclonal antibody targeting inflammation. AbbVie will pay $48 million upfront to OSE […]